Liqomics GmbH
About
At LIQOMICS, we strive to improve cancer treatment. Using a simple blood sample, we analyze circulating tumor DNA (ctDNA) to understand the genetic characteristics of individual tumors. With this liquid biopsy, genetic changes in a tumor can be detected and the amount of remaining tumor can be determined very precisely.
LIFE SCIENCE
DiagnosticsMedical Services
THERAPEUTIC AREA
DiagnosticsHematologyOncology
MEDICINE
Diagnostics, Diagnosis
Representatives
Managing Director
Liqomics GmbH